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INTRODUCTION 
 
Successful outcome is the most desirable end point of any surgical 
procedure.  
Therefore anaesthetic and analgesic techniques should aim not only 
to provide optimal condition for surgery, but also reduce post operative 
morbidity and mortality thus improving  the  outcome. 
The stress response to surgery results in disturbances in body 
homeostasis. 
Many beneficial effects of continuous epidural analgesia during 
post operative period  includes   effective pain relief, fast recovery of gut 
functions, reduction in postoperative thrombo-embolic and cardio 
respiratory complications. 
Analgesia delivered through an indwelling epidural catheter is a 
safe and effective method for the management of post operative pain 
relief. Post operative epidural anaesthesia provides superior analgesia 
compared with systemic opioids. 
Using combination of local anaesthetic and opioids in epidural 
infusion is advantageous over infusion using local anaesthetics or opioids 
alone. 
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A local anaesthetic – opioid combination provides superior post 
operative analgesia –improved dynamic pain relief, limits regression of 
sensory block, decreases the dose of local anaesthetic and decreases the 
incidence of side effects. 
The choice of local anaesthetic for continuous epidural infusion 
varies. Because of differential sensory blockade with minimal impairment 
of motor function local anaesthetics like bupivacaine, ropivacaine, 
levobupivacaine are commonly used. 
Epidural infusion are usually given by intermittent boluses or by 
using syringe pumps or electronic epidural infusion pumps. 
These pumps are electrically driven and they have their own 
disadvantages. 
The newer portable elastomeric infusion pumps can also be used 
for this purpose. They are safe, reliable, economic and easy to use. They 
operate by the action of elastomeric balloon and the drug is infused in a 
constant preset flow rate.  
The present study was designed to compare the post operative pain 
relief by continuous epidural infusion of Bupivacaine with Fentanyl and 
Ropivacaine with fentanyl  using portable elastomeric  infusion pump. 
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AIM OF THE STUDY 
 
TO COMPARE THE POST OPERATIVE PAIN RELIEF 
BY CONTINUOUS EPIDURAL INFUSION OF 
BUPIVACAINE WITH FENTANYL AND ROPIVACAINE 
WITH FENTANYL BY USING PORTABLE ELASTOMERIC  
INFUSION PUMP. 
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HISTORY 
 1885 – American neurologist  JAMES LEONARD CORNING 
(1835- 1723) was the first to give neuroaxial block . He injected  111 mg 
of  Cocaine in Epidural space of healthy male volunteer. 
 1921 – Spanish military surgeon FIDEL PAGES (1886- 1923 ) 
developed the technique of single shot epidural. Later popularised by 
Italian surgeon ACHILLE MARIO DOGLIOTTI (1897) 
 1941 – ROBERT ANDREW HINGSTON and WALDO B 
EDWARDS developed the technique of continuous caudal anasthesia 
using indwelling catheter. The first use of continuous caudal in a 
labouring women was in 1942 
 1947 – MANUEL MARTINEZ CURBELO (1906 – 1962 ) was the 
first to describe the placement of lumbar epidural catheter. 
 
 1956 – Bupivacaine synthesised by EKENSTAM. 
 1963 – Bupivacaine introduced in to clinical practice by 
TELIVUO. 
 1965- MELZOCK and WALTS discovered the Gate control theory 
of pain 
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ANATOMICAL CONSIDERATION 
 
ANATOMY OF THE EPIDURAL SPACE: 
 
 
 Epidural space extends from the foramen magnum to the sacro 
coccygeal membrane and surrounds the dura mater anteriorly, laterally, 
and posteriorly. 
Boundaries 
Anterior  -     posterior longitudinal ligament 
 Lateral        -     pedicles and the inter vertebral foramina  
Posterior    - ligamentum flavum 
 Epidural space narrows posterolaterally and widens again laterally  
towards intervertebral foramina. 
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Compartments in the epidural space : 
By using cryomicrotome,  segmentally distributed compartments  
were observed posteriorly, laterally and anteriorly in the epidural spaces. 
Injected solutions can pass from  compartment to compartment, 
since the dura is not adherent to the canal wall. 
PLICA MEDIANA DORSALIS –fibrous strand extends from 
ligamentum flavum to medial portion of dura producing  possibility of 
unilateral epidural block. 
 
Contents of epidural space : 
Epidural fat 
Epidural veins   
Spinal arteries 
Epidural lymphatics 
Root of spinal nerves with dural cuff 
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Epidural fat : 
This semifluid lobulated areolar tissue extend throughout  the 
epidural space. It is more abundant posteriorly,diminished adjacent to 
articular processes and increases laterally around the spinal nerve root. 
Anteriorly it is sparse.  
 
Overall the amount of fat in the epidural spaces tends to vary in 
direct relation to that present elsewhere in the body. Obese patients have 
generous amount of fat. Epidural fat is vascular  with small capillaries 
forming  a rich network in its substance. The fat has greater affinity for 
drugs with high lipid solubility such as bupivacaine and etidocaine which 
may remain in epidural fat for long periods. 
 
 Compliance of epidural fat varies between individuals and with 
increasing age. In children and young adults it offers little resistance, but 
in some adults  a low compliance may result in considerable  “ drip back”  
of injected local anaesthetics. 
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Epidural veins : 
The large valve less epidural veins are part of the internal vertebral 
venous plexus , they drain the neural tissue of spinal cord, the Cerebro 
Spinal Fluid, and the bony spinal canal.  
Major portion of this plexus lies in the anterolateral part of epidural 
space. 
Major function of the epidural veins is to drain CSF and to transfer 
the local anaesthetics into the CSF. In the region of the dural cuffs, bulbs 
of arachnoid mater  protrude  into epidural space. These protrusions often 
invaginate the wall of epidural veins that drain the spinal cord and nerve 
root area. 
Superiorly  -epidural venous plexus communicates with the 
occipital, sigmoid and basillar venous sinuses within the cranium. 
Inferiorly – anastomosis  by the way of the sacral plexus link the 
vertebral plexus to uterine and illiac veins. 
By the way of the intervertebral foramina at each level, vertebral 
plexus communicate with thoracic and abdominal veins. So pressure 
changes in these cavities are transmitted to the epidural veins 
Distension of epidural veins, owing to direct inferior vena caval 
obstruction or owing to increased intra thoracic and  abdominal pressures, 
will  diminish the effective volume of the epidural space with resultant 
increase in more widespread of local anaesthetics in the space. 
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Spinal arteries: 
Anterior spinal artery arises from the vertebral artery. Posterior 
spinal arteries arises from the posterior inferior cerebellar artery. 
These spinal arteries enter the intervertebral foramina and gain 
access to the spinal cord by the  way of the spinal nerve roots. 
Its is significance to epidural block that spinal branches of 
subclavian, aortic, and iliac arteries cross the epidural space and enters 
the subarachnoid space in the region of the dural cuff.   
The anterior spinal artery territory supplying the anterior horn or 
motor areas of the spinal cord is most vulnerable to injury during epidural 
block. 
 
Epidural lymphatics : 
The dural cuff region is supplied with a rich lymphatic network . 
These lymphatics rapidly removes debris from arachnoid villi out 
through intervertebral foramina to reach lymph channels in front of the 
vertebral bodies. 
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Epidural pressure : 
The epidural space  is identified by the negative pressure in the 
space . The negative pressure  is created by tenting of dura by the  
advancing needle and   transmission of negative intra pleural pressure in 
spontaneously breathing patients. 
 
Positive pressure in epidural space : 
 Causes 
Severe lung disease – emphysema 
Any factor that increase intra abdominal pressure 
Occlusion of inferior vena cava 
 During labour 
Valsalva manoeuvre 
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TECHNIQUES OF CONTINUOUS EPIDURAL 
BLOCKADE WITH PORTABLE INFUSION PUMP 
 
Epidural techniques are widely used for operative anaesthesia, 
obstetric analgesia, post operative pain control, and chronic pain 
management. 
An epidural block can be given at the lumbar , thoracic and 
cervical levels. Sacral epidural technique is known as a caudal block. 
The various approaches  used for epidural blockade are  
1. Midline approach 
2. Paramedian approach 
 
Various types of infusion pumps available 
 1. electronic infusion pump 
 2. syringe pump 
 3.  portable , elastomeric  infusion pump 
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TECHNIQUE OF EPIDURAL BLOCKADE 
 
MIDLINE APPROACH OF LOWER THORACIC, UPPER 
LUMBAR  LEVEL EPIDURAL  PROCEDURES 
 Patient was placed in the lateral position. Under aseptic precaution 
skin was  infiltrated with local anaesthetic solution  upto  the interspinous  
region.  A  17  Gauge Tuohy epidural needle was inserted in the midline. 
Testing syringe was attached to the needle and constant pressure was 
maintained. The epidural space was identified by  using “loss of 
resistance technique” to air   . Then gentle aspiration was done  and test 
dose of 3 ml of 2 % lignocaine with 1:200000 of Adrenaline was  
injected. 19  Guage multi port catheter was inserted  and kept at the depth 
of 5 cm with in the epidural space  and  catheter was  fixed on the back of 
the patient.  
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PHYSIOLOGICAL CONSIDERATION 
 
After epidural injection , the local anaesthetic drugs bind to the 
spinal nerve in the epidural space, spinal nerve rootlets within the CSF 
and within the spinal cord. It enters in to the CSF by means of dural 
sleeves and spinal radicular arteries. Some of the drugs goes into the 
paravertebral space and block the nerves. 
 
RESPIRATORY PHYSIOLOGY 
At mid thoracic level of blockade - pulmonary function test, gas 
exchange and control of breathing are generally preserved in patients 
without pre-existing respiratory diseases. 
Subjective sensation of dyspnea is due to decreased chest wall  
sensation  with inspiration. 
 However tidal volume, respiratory rate, minute ventilation and 
lung volumes are maintained in healthy resting patients. High  block 
height will affect accessory respiratory muscle (abdomen and 
intercostals)  which  plays major role in expiration which in turn reduces 
peak expiratory flow. 
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CARDIAC PHYSIOLOGY 
 Epidural blockade results in a lesser degree of sympathetic block 
and more CVS stability than subarachnoid block.  
 
 Blockade below T4 
   Low thoracic and lumbar epidural block will cause a peripheral 
sympathetic blockade with vascular dilatation in the pelvis and lower 
limb and pooling blood in the abdominal  viscera. This will lead to 
reduced venous return thereby reduced cardiac output. 
 Increased activity of cardiac sympathetic fibres T1 –T4 results in 
increased cardiac contraction and heart rate maintaining normal cardiac 
output.      
Blockade above T4 
 causes decreased heart rate and contraction by acting at 
cardiac sympathetic fibres T1-T4 which leads to bradycardia and 
hypotension. 
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GASTROINTESTINAL, HEPATIC AND GENITO URINARY  
PHYSIOLOGY  
 The sympathectomy of epidural anaesthesia results in relaxation of 
sphincters, contraction of bowels and increased secretion caused by 
parasympathetic predominance. 
 Hepatic blood flow is related to mean arterial pressure and thus 
maintained if the patient is hemodynamically stabe.  
Like wise renal blood flow and perfusion is preserved. 
BLADDER; 
Temporary atonia in lumbar epidural block is due to block of S2-
S4. In continuous epidural block bladder should  be catheterised. 
HYPOTHERMIA 
 Common in epidural block. It  is due to heatloss to the cold 
environment which in turn  due to sympathectomy induced 
vasodilatation. 
 
 
 
 
 
 
 
24 
 
 
PHYSIOLOGY OF PAIN 
 Pain perception requires noxious stimuli, that is transformed from 
its native form by the activated nociceptors to electrical signals which are 
then transmitted along the corresponding nociceptive fibres . These fibres 
in turn synapse to second order neurons in the spinal cord. These 
interneurons are located in the dorsal horn. It is at these interneurons 
where the initial modulation of nociceptive input occurs. From the spinal 
cord nociceptive input is transmitted to the brainstem,  thalamus  and 
cortex. 
 
 
Peripheral neuroanatomy of nociception 
 C and A fibres are the main peripheral nociceptors. The skin, joints 
and periosteum are richly innervated with C and A nociceptors as well as 
the non nociceptive AB sensory fibres. 
  ‘A’  fibres are responsible for sensation of first pain, initial 
sharp pain experienced following an injury. C fibres are unmyelinated 
and are responsible for second pain, the slowly building throbbing 
burning pain experienced following an injury. 
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Peripheral neurochemistry and neurotransmitters 
 Commonly released inflammatory mediators implicated in pain and 
hyperalgesia include bradykinins, potassium, substance P, cytokines, 
histamine, serotonin, prostaglandins. These peripheral neurotransmitters 
either activate or sensitize the peripheral nociceptors to pain. 
Peripheral neuro chemistry :  Algogenic Agents 
 
Algogenic agents Action on nociceptors 
Bradykinin Activates 
Substance P Sensitizes 
Potassium Activates 
Hydrogen Activates 
Arachidonic acid Sensitizes 
Cytokines Sensitizes 
Serotonin Sensitizes 
Noradrenaline High concentration activates and 
sensitizes  
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PAIN PATHWAY 
SPINAL CORD  
 The gray matter of the spinal cord is divided in to ten lamina with 
lamina I –IV representing the doral horn. The dorsal horn is capped by 
the Lissauer’s tract which consist of branches of cutaneous A and C fibres 
and few visceral afferents. 
 Nociceptive fibres terminate in the superficial layers of lamina I& 
II, while the non- painful myelinated fibres terminate in the deeper layers 
of lamina III , IV . Lamina II has the highest concentration of opioids 
receptors in the spinal cord. Modulation and inhibition of nociception 
may occur at this level through the use of opioids . 
 
Ascending sensory pathways 
 Peripheral sensory neurons synapse onto the secondary 
interneurons of the dorsal horn. The axons of the non nociceptive sensory 
neurons travel ipsilaterally in the dorsal column of the spinal cord as 
fasciculus cuneatus ( upper body through T6 ) and fasciculus gracilis ( 
lower body below T6 ) and synapse in thalamus. 
The axons of the nociceptive secondary neurons after synapsing 
travel contralaterally in the anterolateral aspect of the spinal cord as the 
neospinothalamic and paleospinothalamic tracts. 
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 Neospinothalamic tract carries fine discrimination of pain eg. 
location , intensity and first pain.  
 Paleospinothalamic tract responds to noxious stimuli. The 
paleospinothalamic tract synapses in the thalamus, hypothalamus and 
limbic system and play a role in emotional aspects of pain via limbic 
system. The thalamus has multiple connections to limbic system and 
cortex. 
Descending inhibitory pathways 
 The descending controls of pain project specifically onto laminas 
I,II,V of the dorsal horn from mesencephalon, raphenuclei and reticular 
tract.  
The mesencephalon is rich in opioid receptors. This area sends 
excitatory transmission to rostroventral medulla which sends 
noradrenaline and serotonin inhibitory tracts via dorsolateral funiculus to 
lamina I,II,V of spinal cord. 
  The noradrenaline and serotonin fibres mediate transmission 
between the primary afferents and the secondary neurons of the dorsal 
horn. Increased activity of these fibres leads to increased inhibition of 
pain transmission.  
 
 
 
29 
 
 
Locations of opioid receptors 
  Opioid receptors are found in various regions in CNS namely 
cerebral cortex, limbic cortex, hippocampus, hypothalamus, medial 
thalamus, midbrain, peiaqueductal gray matter, extrapyramidal areas, 
susbstantia gelatinosa and sympathetic preganglionic neurons. 
 
  Opioid  receptors are also found in the cardiac sympathetic fibres, 
cardiac branches of vagus, adrenal medulla and gastro intestinal tract. 
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PHARMACOLOGY OF BUPIVACAINE 
 
It  is an amide local anaesthetic characterized as pipecoloxylidides. 
Addition of a butyl group to the piperidine nitrogen of mepivacaine 
results in bupivacaine. It is  a chiral drug ,  because of possession  of 
asymmetric carbon atom. 
 Its was first synthesized in Sweden by Ekenstam and his colleagues 
in 1957 and used clinically by L.J. Telivuo in 1963. 
 It has a molecular weight of 288. 
 
MECHANISM OF ACTION : 
  It prevents transmission of nerve impulses by inhibiting 
passage of sodium ions through ion selective sodium channels in nerve 
membranes.They do not alter the transmembrane potential or threshold 
potential. 
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PHARMACOKINETICS  
 Its is a weak base that has pKa value above physiologic  pH 7.4 .  
Lung is capable of  extracting  bupivacaine from circulation. This 
extraction limits the concentration of drug reaching  the  sytemic 
circulation for distribution to the coronary and cerebral circulations. This 
first pass pulmonary extraction is dose dependent, suggesting that the 
uptake process becomes saturated rapidly.  
 
pKa        : 8.1  
protein binding      : 95 % 
lipid solubility     : 28 
volume of distribution     : 73 litre 
clearance of drug from plasma    : 0.417 lit / min 
elimination half life     : 210min 
onset time       : 10-15 min 
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METABOLISM  
 Undergoes varying rate of metabolism by microsomal enzymes 
located primarily in the liver. 
 Bupivacaine has the slowest metabolism among amide local 
anaesthetics, it undergoes aromatic hydroxylation, N – dealkylation, 
amide hydrolysis and conjugation .  
Only the N – desbutyl bupivacaine has been measured in blood or 
urine after epidural and spinal anaesthesia. 
 Alpha -1 acid glycoprotein is the most important protein binding 
site of bupivacaine. 
 
SIDE EFFECTS 
Bupivacaine is more cardio toxic than equieffective doses of 
lignocaine. This is manifested by severe ventricular arrhythmias and 
myocardial depression.  
 Bupivacaine blocks cardiac Na + channels rapidly during systole 
and dissociates slowly during diastole, so that significant fraction of Na 
channels remain blocked at the end of the diastole. Thus the block by 
Bupivacaine is cumulative and substantially greater. 
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CLINICAL USE :  
Onset of anaesthesia  and  duration of action are long. Its tendency 
to provide more sensory than motor block has made it popular for 
providing post operative analgesia .  
 Used mainly for 
Epidural anaesthesia 
Spinal anaesthesia 
Infiltration anaesthesia 
Field block anaesthesia 
Nerve block anaesthesia 
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PHARMACOLOGY OF ROPIVACAINE 
 
Ropivacaine is a new aminoamide local anaesthetic . It is the 
monohydrate of the hydrochloride salt of  1 –propyl – 2 pipecoloxylidide. 
 
 Pipecoloxylidides were first synthesized in 1957 and have been in 
clinical use for more than 30 years. Ropivacaine has propyl group on the 
piperidine nitrogen atom of the molecule. 
 
 The pipecoloxylidides are chiral drugs because the molecules 
possess a symmetric carbon atom and they may have left (sinister ) or 
right ( rectus ) handed configuration. Ropivacaine is produced as the 
single S – enantiomer. It has an enantiomeric purity of 99.5 % and is 
prepared by alkylation of S –enantiomer of dibenzoyl – L- tartaric acid. 
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PHYSIO – CHEMICAL PROPERTIES 
The physio – chemical properties of Ropivacaine are as follows : 
 1 .molecular weight ( base )             -           274 
 2. pKa       -             8.1 
 3. partition co efficient ( N Heptane/buffer  )  -             2.9 
 4. mean uptake ratio ( rat sciatic  nerve )  -         1.8 
 5. protein binding      -          94 % 
 
PHARMOCOLOGICAL PROPERTIES 
 The relative lipid solubility of ropivacaine as measured by 
portioning studies between N haptane buffer and relative mean uptake 
into rat sciatic nerves, shows ropivacaine to be intermediate between 
bupivacaine and lignocaine. Plasma protein binding marginally less than 
bupivacaine but pKa is identical. 
Onset    - moderate 
Relative potency  - 6 
Duration   - long acting 
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Mechanism of action 
 Ropivacine blocks the generation and conduction of nerve 
impulses, presumably by increasing the threshold for electrical excitation 
in the nerve, by slowing the propagation of the nerve impulses, and by 
reducing the rate of rise of action potential. The propagation of 
anaesthesia is related to the diameter, myelination, and conduction 
velocity of affected nerve fibres. 
Pharmocokinetics 
In human volunteer the pharmacokinetic characteristics  of  
Ropivacine have been determined after intravenous infusion 
Clearance    : 0.82 ±0.16 litres / min 
Plasma protein   : 94 ±1 % 
Volume of distribution  : 59 ±7 liters 
Terminal elimination ½ life : 111±62 min 
Metabolism  in liver by aromatic hydroxylation by cytochrome P 
450 1A to 3- hydroxyl ropivacaine. 
Excretion- 86 % via kidney , 1% as unchanged drug and rest as 
metabolites .The  higher clearance of ropivacaine over bupivacine is 
advantageous in terms of lesser systemic toxicity. 
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Absorption 
 The systemic concentration of Ropivacaine is dependent on the 
total dose and concentration of drug administered, route of 
administration, the patients hemodynamic condition and the vascularity 
of the administration site. 
 From the epidural space, Ropivacaine has complete and biphasic 
absorption. The half lives of the two phases are 14 ±7 minutes and 4.2 
±0.9 hours ( mean ± SD ) respectively. The slow absorption is the rate 
limiting factor in the elimination of Ropivacaine, which is why the 
terminal half life is longer after epidural than after intravenous 
administration.  
 
Distribution 
          After intravascular infusion, Ropivacaine has a steady state volume 
of distribution  of 59 ± 7 litres . 
 Ropivacaine is 94 % protein bound, mainly to α1 acid 
glycoprotein .  
 An increase in total plasma concentration during continuous 
epidural infusion has been observed, which is related to postoperative  
increase of α 1acid glycoprotein. 
           Variation in unbound,  i.e  pharmacologically active concentration 
have been less than total plasma concentration. 
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 Ropivacaine readily crosses the placenta and  equilibrium is 
reached rapidly  in regard to unbound concentration. 
 
Metabolism  
           Ropivacaine is extensively metabolized in the liver , 
predominantly by aromatic hydroxylation mediated by cytochrome P450 
1A to 3 – hydroxyl Ropivacaine. 
 Approximately 37 % of the total dose is excreted in the urine as 
both free and conjugated 3- hydroxyl ropivacaine . Urinary excretion of 
the 4 –hydroxyl and both 3 – hydroxyl and 4- hydroxyl N – dealkylated 
metabolites account for less than 3 % of the dose. 
An additional  metabolite 2 – hydroxyl methyl ropivacaine has 
been identified but not quantified in the urine . Both 3 – hydroxyl and 4- 
hydroxyl ropivacaine have not quantified in the urine. Both 3 – hydroxyl 
and 4-hydroxyl  ropivacaine have a local anaesthetic activity in animal 
models less than that of ropivacaine.  
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Elimination  
          The kidney is the main excretary organ for most local anaesthetic 
metabolites. In total 86 % of ropivacaine dose is excreted in the urine 
after intravenous administration. 
        Ropivacaine has a mean total plasma clearance of 387 ± 107 ml 
/min. The mean ± SD terminal half life is 1.8 ± 0.7 hours after  
intravascular  administration and 4.2 ±1.0 hours after  epidural 
administration . 
 
PHARMOCODYNAMICS 
Primary pharmocodynamics ( Animal studies ) 
 These studies showed that ropivacaine at low concentration 
produced a profound rapid block of both Aδ and C fibres and was more 
potent than similar low concentrations of bupivacaine. 
At higher concentrations  ropivacaine and bupivacaine had similar 
blocking properties.  Aδ fibre blocking was 16 % greater with 
bupivacaine and the degree of C fibre block  was similar with both drugs. 
Ropivacaine is a potent producer of frequency dependent blocks  ( i.e ) a 
block that occurs only when the fibre is stimulated. Ropivacaine blocks  
C  fibres  faster than  A fibres. 
40 
 
Low pKa and high lipid solubility of a local anaesthetic dugs 
favoured A over C fibre block. The lower lipid solubility of ropivacaine 
over bupivacine is presumed to reduce penetration in to myelin sheath. 
This greater degree of differential block with ropivacaine at low 
concentration and the property of producing frequency  dependent block 
were considered to offer clinical advantage in providing analgesia with 
minimal motor block. 
 
Secondary pharmacodynamics 
Addition of epinephrine to ropivacaine has no limiting effect on the  
systemic absorption of ropivacaine . Systemic absorption can produce 
effects on the central nervous  and cardiovascular systems. At blood 
concentration achieved with therapeutic doses , changes in cardiac 
conduction, excitability , refractoriness, contractility and peripheral 
vascular resistance are minimal . However toxic blood concentration 
depress   the cardiac  conduction and excitability , which may lead to 
atrioventricular block, ventricular arrhythmias and cardiac arrest. In 
addition myocardial contractility is depressed and peripheral 
vasodilatation occurs , leading to decreased cardiac output and arterial 
pressure.  
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Ropivacaine can produce central nervous system stimulation,  
depression or both. Apparent central stimulation is usually manifested as  
restlessness, tremors, shivering, progressing to convulsions followed by  
depression and coma  progressing to respiratory arrest. However 
ropivacaine has a primary depressant effect on the medulla and higher 
centers . The depressed stage may occur without a prior excited stage. 
 
Adverse reactions  
 A major cause of adverse reactions due to excessive plasma levels 
that may be due to overdosage, unintentional intravascular injection or 
slow metabolic degradation. Most adverse events reported were mild and 
transient. 
 
Central nervous system reactions 
 These are characterised by excitation and depression, restlessness,  
anxiety , dizziness, tinnitus, blurred vision , tremors and  proceeding to 
convulsions. However  excitement may be transient or absent with 
depression being the first manifestation. This may quickly  followed by 
drowsiness, unconsciousness and respiratory arrest. Other effects may be 
nausea , vomiting, chills and constriction of pupils. 
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Cardiovascular system reactions 
 High doses of accidental intravascular injection may lead to high  
plasma levels and  depression of myocardium, decreased cardiac  
output, heart block, hypertension, bradycardia and ventricular arrhythmia  
including ventricular tachycardia and ventricular fibrillation and  
cardiac arrest.  
 
PREPARATIONS AVAILABLE 
0.2 % 
0.5% 
0.75% 
1 % 
Uses : 
1 . infiltration 
2.  peripheral nerve block 
3. brachial plexus block 
4. lumbar epidural anaesthesia 
5. sub arachnoid block  
6.  caudal block  
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FENTANYL 
 
phenyl piperidine derivative, synthetic opioid agonist , structurally 
related to meperidine,  
75 – 125 times potent than morphine. 
 
PHARMACOKINETICS 
 Single dose of IV fentanyl produce more rapid onset and shorter 
duration of action- reflects the greater lipid solubility which facilitate its 
passage across blood brain barrier.  
 Shorter duration – reflects its rapid redistribution to inactive tissue 
sites to fat and skeletal muscles associated with decrease in plasma 
concentration. 
44 
 
 Estimated 75 % of the initial dose undergoes first pass pulmonary 
uptake. 
 Multiple IV doses or continuous infusion of drug produce 
progressive saturation of these inactive tissue site – plasma concentration 
doesnot decreases rapidly and duration of analgesia and depression of 
ventilation prolonged.  
METABOLISM 
 By demethylation produces norfentanyl and excreted in urine. 
 ELIMINATION HALF TIME  
 Longer than morphine . This longer t1/2 reflects a larger volume of 
distribution. Larger volume of distribution is due to its greater lipid 
solubility and more rapid passage in to tissues.  
 Plasma concentration of fentanyl are maintained by slow reuptake 
from inactive sites. 
CONTEXT SENSITIVE HALF TIME  
  As a duration of continuous infusion of fentanyl increases beyond 
about 2 hours, context sensitive half time of fentanyl becomes greater 
than fentanyl. This reflects saturation of  inactive sites with fentanyl 
during prolonged infusion and return of the opioids from peripheral 
compartment to the plasma. 
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CLINICAL USES 
1. Low dose of fentanyl 1- 2 μg / kg used for intra operative analgesia. 
2. Fentanyl 2- 20 μg / kg IV  blunts the circulatory response to – direct 
laryngoscopy of intubation and sudden changes of surgical 
stimulation. 
3.  Large dose 50- 150 μg /kg used for induction – lacks direct 
myocardial depressant effect, does not cause histamine release, and 
suppresses  the stress of surgery. 
4. Transmucosal preparation – lozenges designed to deliver 5-20 μg /kg 
decreases preoperative anxiety, facilitate the induction of anaesthesia. 
5.  Transdermal fentanyl. 
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SIDE EFFECTS 
Persistent/ recurrent depression of ventilation 
Cardiovascular – bradycardia, Hypotension  
Allergic reaction 
Seizure like activity 
Changes in somatosensory evoked potential 
Moderate increase in intracranial tension despite maintenance of 
unchanged PaCO2 
Drug interaction 
 Analgesic concentration greatly potentiate the effect of midazolam,  
 Decreases the dose requirement of propofol. 
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PHARMACOLOGY OF TRAMADOL 
 Tramadol is a centrally acting opioid analgesic that has a low 
affinity for mu receptors . 
  5 to 10 times less potent than morphine. 
Mechanism of action: 
 Inhibit norepinephrine and 5 –hydroxytryptamine  neuronal uptake 
and to facilitate 5-hydroxytryptamine release. It affect central 
catecholamine pathway directly by preventing norepinephrine uptake. 
 
 Tramadol is a racemic mixture of two enantiomers, one of which 
responsible for inhibiton of norepinephrine uptake and other is 
responsible for inhibition of 5 – hydroxytryptamine uptake and 
facilitation of its release. 
 
A major metabolite of tramadol is O – desmethyltramadol. 
Tramadol administered orally, IM or IV for the treatment of 
moderately severe pain.  
 
The recommended adult dose is 50-100mg every 4 to 6 hours. 
IV tramadol has an  insufficient sedative effect to make it a useful 
drug for intraopertive administration as an analgesic. 
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High incidence of nausea, vomiting is a draw back to the 
perioperative use of this drug. 
 
Tramadol is useful for the treatment of chronic pain because it 
doesnot cause tolerance or addiction.  
 
Seizure have been associated with tramadol administration 
especially in patients receiving concomittent treatment with 
antidepressant. 
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EPIDURAL INFUSION PUMPS 
  
This is portable, manual , elastomeric pumps 
 
Contains  
1. Air and portable filter 
2.  Capillary design reduces obstruction  
3. No battery or  electrically driven – can shower with it 
4. Disposable and easy to fill with hands  
5. Large capacity 
6. Available in fast and slow flow rates  
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Advantages of portable infusion pump 
1. Safe and simple , reliable and economical  
2. No alarm 
3. No need for complicated infusion pump 
4. Easy to use , reduces the training cost 
5. Minimize multiple nursing visits 
6. Wide selection of volume  and flow rate 
Applications 
 Designed for a continuous intra venous and subcutaneous and 
epidural infusion of drugs for use in  
1. Post operative pain relief 
2. Chemotherapy 
3. Patient controlled analgesia 
Features  
 Unique flat capillaries assures a steady flow rate 
Flat capillary has a wide internal diameter and greater length than 
capillaries of similar devices.  
Minimizes risk of capillary obstruction and improves stability and 
precision of infusion 
Balloon is very stable producing a linear infusion profile which 
minimises dosage peaks 
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Capacity  
 65 ml 
 150 ml 
 250 ml 
Flow rate  
 2ml / hour 
 4ml /hour 
 5ml/ hour 
 10ml / hour 
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REVIEW OF LITERATURE 
 
 Fernandes et al  have  done a study to compare the analgesic 
efficacy and degree of motor blockade achieved with epidural infusion of 
0.625 % Bupivacaine (  group B ) Vs  0.1 % Ropivacaine ( Group R ) 
both with Fentanyl 2 μg /ml in labouring patients. 
 
 A prospective double blind study was performed in 98 ASA 
physical status  I – II parturient who were divided randomly in to 2 group 
to receive either Bupivacaine and Ropivacaine after catheter location has 
been tested with an initial bolus of lidocaine and fentanyl . Infusion rate 
was 15 ml/ hour in every case. When pain was perceived, 5 ml bolus of 
assigned epidural analgesics were administered every 10 min until 
analgesia was achieved. 
 
 They recorded pain intensity, level of sensory block, degree of 
motor block, haemodynamic variables, secondary effects, mode of 
delivery, neonatal out come, patient satisfaction. There were no 
statistically significant difference in any of the factors analysed. Highly 
effective analgesia was achieved in both groups with a small incidence of 
motor block. These finding suggested that bupivacaine may be more 
potent than ropivacaine. 
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Hudgson PS, Liu SS have done a study, A comparison of 
ropivacaine  to bupivacaine with fentanyl for post operative patient 
controlled epidural analgesia. 
 
 Fourty patients undergoing abdominal surgery were randomized in 
a double blinded manner to the following : 0.05 % bupivacaine / 4 
microgram fentanyl , 0.1 % bupivacaine/fentanyl, 0.05 % ropivacaine / 
fentanyl  or 0.1 % ropivacaine/ fentanyl for standardized PCEA. They 
measured pain scores , side effects, and PCEA consumption for 42 h. 
Lower extremity motor function was assessed. 
 
 Analgesia was equivalent among groups. Local anaesthetic use was 
more in the 0.1 % bupivacaine and 0.1% ropivacaine groups. Motor 
function decreased during PCEA and was equivalent among groups. 
Eight patients were transiently unable to ambulate. These patients used 
more local anaesthetic with additional decrease in motor function 
compared with ambulating patients. Other side effects were mild and 
equivalent among solutions.  
 
 Scott DA et al have done a study on post operative analgesia using 
epidural infusion of fentanyl with bupivacaine – A prospective analysis of 
1014 patients. 
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 They observed that post operative epidural fentanyl / bupivacaine 
infusions are effective and can be managed readily in general wards with 
minimal complications provided that appropriate observation are 
performed. 
 
Cooper DW, Turner G have done a study on patient controlled 
extradural analgesia to compare bupivacaine , fentanyl, bupivacaine with 
fentanyl in the treatment of post operative pain. 
 
 They have assessed the effect of combining extradural bupicacine 
and fentanyl in 60 orthopedic patients who received 0.125 % bupivacaine 
fentanyl 5 microgram/ml or 0.125 % bupivacaine with fentanyl 5 micro 
gram /ml, delivered by patient controlled extradural analgesia for 24 h via 
lumbar extradural catheter. 
 
 They observed that adding bupivacaine to fentanyl reduced mean 
bupivacaine administration from 113 ml to  89 ml. There was no 
significant difference between the groups in pain , nausea , motor block, 
pruritis, sedation. No patients had a ventilatory frequency less than 10 per 
min.  Hypotension occurred in two of 20 patients in the fentanyl group, 
compared with eight of 19 in the bupivacaine group and ten of 21 in the 
combined group. 
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 They concluded that extradural bupivacaine and fentanyl were 
additive in their analgesic actions , resulting in decreased requirements of 
each individual agents. 
 
Zaric D, Nydahl PA et al, have done a study to investigate the 
dose response of sensory and motor block during continuous epidural 
infusion of 0.1%,0.2% or 0.3 % ropivacaine in volunteers in a double 
blinded manner. Bupivacaine 0.25 % and isotonic saline were used as 
reference and control respectively. 
 
 Each treatment group consisted of eight healthy men. After a bolus 
dose of 10 ml at the L2-L3 interspace, solution in question was infused at 
10 ml/hr for 21 hours. Sensory block was evaluated by pin prick, light  
touch and thermotest methods. Motor block was measured by the 
bromage scale. Mobilization of the subjects was attempted through out 
the investigation. 
 
 The number of blocked dermatomes with 0.1 % ropivacaine was 
significantly smaller than with the other test solutions. Motor block was 
minimal with 0.1% ropivacaine. It was moderate with 0.2 and 0.3 % 
ropivacaine and most intense with 0.25 % bupivacaine. The regression 
phase was significantly shorter with all three concentration of ropivacaine 
than with bupivacaine. 
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 They concluded that ropivacaine 0.1 % produced limited analgesia 
and minimal motor block and ambulation was possible throughout the 
investigation. With 0.2% and 0.3 % ropivacaine, analgesia was more 
extensive and motor block was considered moderate.  
 
David A Sidebottom, Kevin Russel et al have done a 
retrospective study to assess the clinical efficacy of addition of low 
concentration of fentanyl to bupivacaine 0.125 % which infused 
epidurally for postoperative analgesia. 
 
Three patient group received bupivacaine 0.125 % alone (n70 ), 
bupivacaine 0.125 % with 1 ug/ml fentanyl (n 109 ), bupivacaine 0.125 % 
with fentanyl (n 70 ). 
 
The percentage of patients with adequate analgesia – pain score < 
3, was higher in both fentanyl groups compared to the plain bupivacaine 
with the p value  <0.05. 
 
Those receiving plain bupivacaine had a greater incidence of 
patchy blocks compared to both fentanyl group – p value <0.01. 
 
The higher dose of fentanyl was associated with greatly increased 
length of stable analgesia – p value <0.01. 
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Patient satisfaction score were higher in the 2ug /ml fentanyl group 
and lowest in the plain with significant difference between all groups – p 
value <0.01 
 
The incidence of nausea was higher in the plain bupivacaine group 
compared to both fentanyl group – p <0.001. 
 
Other side effects were similar between the group. 
The study conclude that the addition of fentanyl 1-2 ug /ml to 
bupivacaine 0.125 % for continuous epidural infusion significantly 
improved all indicators of analgesia with out and attendant increase in 
side effects . 
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MATERIALS AND METHODS 
 
 After  approval of the study by our institutional  ethics committee, 
the study was conducted on  50 patients of either sex aged between 30- 60 
years with American society of Anaesthesia physical status grade I  who 
were undergoing  upper and middle  abdominal surgery. Age of the 
patients ranged from 20 – 60years and weight  between 40-70 kg and 
height ranging from 150 – 180 cm. All patients were thoroughly 
examined preoperatively. Informed consent was obtained from all of 
them.  
 
In the assessment room , vital parameters like pulse , blood 
pressure and base line investigations like haemoglobin, urine analysis for 
albumin and sugar , blood sugar, urea and creatinine and chest X ray PA 
view , ECG were checked. Thorough examination of the all the systems 
and airway assessment was done. 
 
Exclusion criteria including significant co – existing diseases, long 
term analgesic use, and contraindication to regional anaesthesia such as 
local infection and bleeding diathesis. 
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PATIENTS WERE RANDOMLY ALLOTTED TO 2 GROUPS 
CONTAINING 25 EACH. 
 
GROUP BF 
Patients received     
60 ml of 0.5 % Bupivacaine + 
10 ml of Fentanyl (100μg )+  
180 ml of Normal saline       
 in 250 ml of infusion pump 
 
 
GROUP RF 
Patients received    
60 ml of 0.5 % Ropivacaine +        
10 ml of Fentanyl (100 μg ) +        
180 ml of Normal Saline        
 in 250 ml of infusion pump. 
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Epidural infusion pump used in this study was DOSIFUSER  
portable, elastomeric pump  with the capacity of 250 ml  with the  fixed 
infusion rate of 5.2 ml /hr.  
 
 
Concentration of anaesthetic  mixture used in this study  
 
Group BF –  
  Concentration –  Bupivacaine – 0.125% 
     Fentanyl  – 2 μg/ml 
Group RF –  
  Concentration –  Ropivacaine – 0.125 % 
Fentanyl – 2 μg/ml 
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Anaesthetic management  : 
  In the operating theatre  the Boyles apparatus , emergency drugs 
and airway devices were kept ready. Patients were shifted to operating 
table. NIBP, ECG , Pulse oximetry were connected to the patients. 
Preoperative baseline systolic and diastolic blood pressure , Pulse rate,  
oxygen saturation were recorded. Patients were cannulated with 18 g IV 
cannula and IV fluid RL started. The patients were placed in right lateral 
position. The skin over the back was prepared with antiseptic solution and 
draped with sterile towel. After infiltrating skin and subcutaneous tissue 
with local anaesthetic , 17  G Tuohy needle inserted either in T12 –L1 or 
L1-L2 or L2-L3 space according to nature of the surgery .  Epidural space 
was located with loss resistance to air and 19 Gauge  epidural catheters 
inserted and placed at depth of 5 cm after giving test dose of 3 ml of 2 % 
lignocaine with 1:200000 dilution of adrenaline, 
 
 All patients in both group received  General anaesthesia as 
intraoperative anaesthesia .General anaesthetic technique was similar in 
both the groups.  
 
 Intraoperatively all patients were managed depending upon the 
patients preoperative status and type of the surgery. IV fluids & blood 
transfusions were given according to haemodynamic monitoring and 
blood loss. 
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  30 min before the end of the surgery epidural infusion was started, 
and time was noted . 
 
 At the end of surgery neuro muscular blockade was antagonised 
and tracheal extubation was done provided the patients were conscious, 
haemodynamically stable and maintained adequate ventilation. 
 
 All the patients were shifted to post operative surgical ward. Each 
patient’s post operative course was followed for the 48 hours since 
activation of continuous epidural infusion. 
 
 Patients pulse rate, blood pressure. Respiratory rate, SpO2, Pain 
score using Visual Analogue Scale , Sedation score using Ramsay scale, 
Motor block using bromage scale and any complications were noted 
every 8 hourly. 
 
Break through pain was managed with Inj Tramadol 50 mg  IV. 
 
After 48 hours infusion pumps were stopped and   epidural catheter 
was removed 
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PARAMETERS OBSERVED 
 
1. POST OPERATIVE PULSE RATE 
2. POST OPERATIVE SYSTOLIC AND DIASTOLIC   BLOOD     
PRESSURE 
3. RESPIRATORY RATE 
4. SPO2 
5. PAIN SCORE 
6. SEDATION SCORE 
7. BREAK THROUGH PAIN AND ADJUVANTS USED 
8. ANY COMPLICATION – LIKE NAUSEA , VOMITTING, 
PRURITIS 
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VISUAL ANALOGUE SCALE 
 Used to assess the severity of pain.  
 
0-          No pain 
1-        
2-          Mild pain 
3-  
4-           Moderate pain 
5-  
6-           Severe pain 
7-  
8-            Very severe pain 
9-  
10- Worst possible pain 
   
RAMSAY SEDATION SCORE 
1. Patient anxious and agitated or restless of both 
2. Patient cooperative, oriented, and tranquil 
3. Patient responds to commands only 
4. Brisk responds to commands only 
5. Sluggish response to light glabellar tap or auditory stimulus 
6. No response to stimuli mentioned in items 4 and 5 
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OBSERVATION AND RESULTS 
 
OBSERVATIONS AND ANALYSIS 
 The informations collected regarding all the selected cases were 
recorded  in a Master chart. Data analysis was done with the help of 
epidemiological information package (2008) 
 
 Using this software range , frequencies, percentages , means , 
standard deviations ,   p values were calculated. ‘P  value’ was calculated 
using students t test. A “ p” value of less than 0.05 is taken to denote 
significant results. 
 
OBSERVATION AND RESULTS 
 This study comprised two groups. 
 The patients in group BF received  0.5 % Bupivacaine 60 ml + 10 ml 
Fentanyl (100 μg ) +180 ml Normal Saline. 
 
 In group RF  received 60 ml  of   0.5 %Ropivacaine + 10 ml  Fentanyl + 
180 ml Normal Saline  
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DEMOGRAPHIC DATA    
1. AGE  
Age  distribution in the group BF  varied from 26 years to 60 
years with mean age of 43 years and standard deviation of 13 . 
In group RF age varied from 25 years to 60 years with mean 
value of 42 years and standard deviation of  10 . 
 
      2 . HEIGHT  
Height of the patients in the group BF had a mean value of 
164 cm    with the   standard deviation of 6 . 
 In group RF  had a mean value of 160 cm with standard 
deviation of   6.4 . 
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3. WEIGHT 
       Weight of the patients in the group BF had a mean value of 
64.7kgs  with standard deviation of 5. 
       In group RF  had mean value of 61.28 kgs with standard 
deviation of 7. 
 
DEMOGRAPHIC DATA 
 
 
FACTORS 
 
BUPIVACANIE-
FENTANYL 
 
ROPIVACAINE -
FENTANYL 
 
AGE 
 
43 ± 13 
 
42 ± 10 
 
HEIGHT 
 
164 ± 6 
 
160 ± 6.4 
 
WEIGHT 
 
64.7 ± 5 
 
61.28 ± 7 
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4. PULSE RATE  
         In the  BF group mean preoperative pulse rate was 81with 
standard deviation  of 5. The post operative  mean pulse rate was 81 with 
standard deviation of 4.25 .   The p value between two was 0.54, that was 
not statistically significant. 
 
In the RF group mean preoperative pulse rate was 80 with standard 
deviation of 6.29. The mean post operative pulse rate was 92.9 with 
standard deviation of 8.36.  The p value between two was < 0.0001,that  
was  statistically significant 
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5. BLOOD PRESSURE – SYSTOLIC 
 In BF group mean preoperative systolic BP was 121 with standard 
deviation of  3.04. The mean post operative systolic BP was 123 with 
standard deviation of 4.24. The p value between two was 0.484 that not 
significant. 
 In the RF group the mean preoperative systolic BP was 121.52 
with standard deviation of 4.51. The mean post operative systolic BP was 
127.68 with standard deviation of 3.68. The p value < 0.0001 was 
statistically significant. 
 
 
 
 
 
 
 
74 
 
BLOOD PRESSURE – SYSTOLIC 
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 6. DIASTOLIC BLOOD PRESSURE 
 In the BF group mean preoperative diastolic BP was 70 with 
standard deviation of 4.24. The mean post operative  diastolic BP was 71 
with standard deviation of 4.62 . The p value is 0.429 that is not 
significant 
 In the RF group the mean preoperative diastolic blood pressure 
was 77.012 with standard deviation of 5.83. The mean post operative 
diastolic BP was 82.21 with standard deviation of 3.20. The p value 
0.0004 which was highly significant. 
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DIASTOLIC BLOOD PRESSURE 
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BLOOD PRESSURE: 
  BUPIVACAINE  
 
ROPIVACAINE  
 SYSTOLIC DIASTOLIC
 
SYSTOLIC 
 
 
DIASTOLIC
 
 
PRE 
OP 
 
121 ± 3.04 
 
70 ± 4.24 
 
121.52 ± 4.51 
 
77.1 ± 5.83 
 
POST 
OP 
 
123 ± 2.18 
 
71 ± 4.62 
 
127.68 ± 3.68 
 
82.21 ± 3.20
 
P value 
 
0.484 
 
0.429 
 
<0.0001 
 
<0.0004 
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PAIN SCORE 
 The mean pain score in the BF group was 2 with  standard 
deviation of 0.29. 
In the RF group the mean pain score was 2.17 with standard 
deviation of 0.706. 
The p value between two was 0.0204 that was statistically 
significant. 
 
 
 
GROUP 
 
PAIN SCORE 
 
BUPIVACAINE - FENTANYL 
 
2  ±  0.29 
 
ROPIVACAINE- FENTANYL 
 
 
2.17± 0.706 
 
P value 
 
 
0.0204 
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ADJUVANTS NEEDED : 
 BF group needed  6 times of rescue analgesia 
  RF group needed 22 times of rescue analgesia 
 
GROUP NO OF TIMES ADJUVANT 
BUPIVACAINE  
FENTANYL 
 
6 
ROPIVACAINE- 
FENTANYL 
 
22 
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DISCUSSION 
Portable , elastomeric  epidural infusion pumps is an economical 
and more reliable mode of delivering the drugs. It was available in 
various volume, and variable flow rates.It provides continuous delivery of 
drug according to the flow rate for fixed hours.  
For continuous epidural analgesia local anaesthetics with opioids 
combination were commonly used. 
 Bupivacaine, Ropivacaine, levobupivacaine are the commonly used 
local anaesthetics,  because of their differential blockade of sensory fibres 
rather than motor fibres. 
 Local anaesthetics are used in the concentration of <0.125 to 0.2 % 
 Opioids commonly used are Fentanyl, Sufentanil, morphine , 
hydromorphine . 
Local anaesthetic and opioid combination in epidural infusion 
provides superior post operative analgesia, decreases the dose of local 
anaesthetic and reduces the side effects.  
       By statistical analysis of two groups the age distribution in both 
groups was statistically not significant with a p value of  0.8 
 When comparing the weight of the patient in two groups it was 
statistically not significant with p value 0.78 
 There was no statistically significant differences between the two 
groups as regards to sex distribution 0.89. 
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Pre and post operative pulse rate ; 
 Mean preoperative pulse rate in BF group was 81 ±5 and post 
operative pulse rate was 81 ±4.25 .  The difference between two was 
statistically not significant ( p> 0.54 ) 
 Mean preoperative pulse rate in RF group was 80 ± 6.29 and post 
operative pulse rate was 92.9 ± 8.36. The difference between two was 
statistically significant ( p < 0.0001 ) 
 
Blood pressure – systolic  
 Mean preoperative systolic BP  in BF group was 121 ± 3.04 , and 
mean post operative blood pressure was 123 ± 2.18 . The difference 
between two was statistically not  significant (  p  0.484 ) 
 Mean preoperative systolic BP in RF group was 121.54± 4.51 , and 
mean post operative systolic BP was 127.68 ± 3.68 . The difference 
between two was statistically significant  with p value of < 0.0001.  
 
Blood pressure – diastolic  
 Mean diastolic BP in BF group was 70 ±4.24 and mean post 
operative diastolic BP was 71 ± 4.62 . The difference between two was 
statistically not significant with a p value 0.429 
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 Mean diastolic BP in RF group was 77.12  ± 5.83 and mean post 
operative diastolic BP was 82.21 ± 3.20 . The difference between two 
was statistically significant with p value  < 0.0004 
 
Post operative pain score  
 Mean post operative pain score in the BF group was 2 ± 0.29 and 
in  RF group it was 2.17 ± 0.706 . The difference between two was 
statistically significant with p value of 0.0204.   
 
Number of time adjuvants needed  
 Adjuvants are needed 6 times in BF group.  
 In RF group adjuvants was used in 22 times. 
Post operative sedation score was equal in both groups. 
Post operative respiratory rate and Sp02 was equal in both group. 
No significant complication between two groups.    
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SUMMARY 
50 patients of ASA grade I who  underwent  upper  and  middle   
abdominal surgeries were randomly assigned  into  two  groups, Group 
BF and Group RF. 
Surgery was done under general anaesthesia. Thirty minutes before 
the end of  the surgery continuous epidural infusion was started with 
portable elastomeric infusion pump having the flow rate of 5.2 ml / hr 
The patients in group BF received 60 ml of 0.5 % Bupivacaine and 
10 ml of Fentanyl(100μg)  and 180 ml of Normal saline 
In group RF patients received 60 ml of 0.5 % Ropivacaine and 10 
ml of Fentanyl(100μg) and 180 ml Normal saline. 
Parameters observed every eight hours after start of infusion pump 
were , post operate pulse rate, systolic and diastolic blood pressure , 
respiratory rate, spo2, Pain score, sedation score, no of time adjuvant 
drug used and side effects. 
 
This study with  continuous epidural infusion by single use 
infusion pump for 48 hours shows that 
 1. Bupivacaine with fentanyl provide superior  postoperative pain 
relief compared  With Ropivacaine with Fentanyl. 
 2. Bupivacaine with Fentanyl  maintains stable heamodynamic of 
post operative pain relief compared with Ropivacaine with Fentanyl 
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CONCLUSION 
 
 By using portable, elastomeric epidural infusion pump for the 
purpose of post  operative analgesia by continuous epidural infusion of 
Bupivacaine with Fentanyl provides superior analgesia compared to 
Ropivacaine with Fentanyl. 
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CONTINUOUS EPIDURAL INFUSION OF BUPIVACAINE 
WITH  FENTANYL AND ROPIVACINE WITH FENTANYL 
FOR POST OPERATIVE PAIN RELIEF BY USING 
PORTABLE, ELASTOMERIC INFUSION PUMP 
 
Name :                                    Age :                      Sex :          Date : 
 
Height :        Weight : 
 
Ward :       IP No : 
 
Diagnosis :      Surgery : 
 
ASA Grade : 
 
Catheter insertion site :    Depth of catheter : 
 
Infusion mixture       :    Infusion rate : 
 
Intra operative anaesthesia : 
 
Infusion starting time : 
 
Complications  : 
 
Infusion termination time : 
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PRE OPERATIVE  
 
 
TIME 
 
PULSE 
RATE 
 
BP 
 
Sp02 
 
RESPIRATORY 
RATE 
     
 
POST OPERATIVE  
 
TIME 
IN HR 
 
PR 
 
BP 
 
SPO2 
 
RR 
 
SEDATION 
SCORE 
 
PAIN 
SCORE 
 
MOTOR 
BLOCK 
 
ADJUVANT 
DRUGS 
         
         
         
         
         
         
 
 
BUPIVACAINE FENTANYL GROUP
NAME AGE SEX
PREOP 
DIA BP
POST 
OP 
DIAST 2 3 4 5 6 AVERAGE SPO2 RR
Pannerse 48 m 70 72 68 64 70 62 74 68 98 18
Veerama 48 m 66 62 68 66 72 74 70 68.66666667 98 18
Perumal 55 m 72 74 72 78 64 80 74 73.66666667 99 20
Thiagara 47 m 70 78 76 74 68 70 66 72 98 22
Kanman 30 f 70 72 78 72 68 64 66 72 99 20
Latha 28 f 66 64 68 66 70 64 68 66.66666667 98 18
Pandarin 52 m 62 68 66 60 62 60 64 63.33333333 99 20
Veerama 48 M 66 64 68 64 66 70 64 66 98 18
Ramasam 60 m 72 70 78 74 76 74 72 74 98 16
Ragavall 48 f 70 72 70 68 70 74 72 71 99 18
periyana 55 f 62 62 60 62 64 62 64 62.33333333 97 18
Mala 21 f 62 62 64 62 60 62 64 62.33333333 99 20
Radha 60 f 72 72 68 70 74 76 78 73 99 22
Saraswat 53 f 70 72 74 68 66 68 70 69.66666667 98 18
Vetriselv 35 f 70 66 68 64 80 78 74 71.66666667 99 18
Mookaye 50 f 66 66 64 68 70 64 64 66 97 16
Saraswat 53 f 70 68 64 68 72 74 70 69.33333333 98 22
Radha 60 f 76 70 74 84 78 76 86 78 99 20
lakshmi 42 f 72 72 76 74 78 72 74 74.33333333 98 18
Selvi 27 f 78 80 82 86 78 74 84 80.66666667 99 16
Ramayee 48 f 76 78 76 74 80 78 74 76.66666667 97 18
Prabhaka 16 m 72 68 70 72 74 70 82 72.66666667 98 20
Philip 49 m 72 78 74 76 72 68 66 72.33333333 99 20
Rajeswa 25 f 74 72 74 76 74 70 74 73.33333333 98 18
Parames 28 f 70 68 64 66 70 72 76 69.33333333 98 18
43.44 70 71
13.125 4.239497 4.625733175
BUPIVACAINE FENTANYL GROUP
NAME AGE SEX HEIGHT WEIGHT
PREOP 
SYS BP
POST OP 
BP 2 3 4 5 6
POST OP 
SYST
Pannerselvam 48 m 168 68 118 120 122 126 120 118 124 122
Veeramalai 48 m 170 72 122 118 120 116 124 128 126 123.5
Perumal 55 m 168 66 120 123 126 118 122 128 120 122.8333
Thiagarajan 47 m 174 72 118 124 122 116 118 126 114 120.4
Kanmani 30 f 164 68 116 112 120 126 114 118 116 117.6667
Latha 28 f 168 65 118 118 124 128 116 112 126 121.4286
Pandarinathan 52 m 170 72 120 124 128 126 114 126 112 123.4286
Veeramalai 48 M 162 50 124 130 128 134 126 122 118 126.3333
Ramasamy 60 m 168 68 122 124 132 118 116 122 130 123.6667
Ragavalli 48 f 158 56 120 128 114 124 118 126 124 122.3333
periyanayaki 55 f 160 68 120 126 118 116 120 124 128 122
Mala 21 f 162 64 118 118 124 122 126 116 126 122
Radha 60 f 168 67 116 124 128 118 120 114 124 121.3333
Saraswathy 53 f 166 68 118 114 118 120 126 128 124 121.6667
Vetriselvi 35 f 164 64 120 130 132 122 124 128 126 127
Mookayee 50 f 156 66 124 128 126 134 118 124 126 126
Saraswathy 53 f 154 64 126 118 114 124 126 130 124 122.6667
Radha 60 f 158 66 118 128 124 118 130 116 114 121.6667
lakshmi 42 f 162 68 121 122 126 120 124 132 126 125
Selvi 27 f 168 54 122 118 116 122 124 114 120 119
Ramayee 48 f 156 58 120 114 124 118 126 120 126 121.3333
Prabhakar 16 m 166 59 122 126 128 118 122 128 124 124.3333
Philip 49 m 174 68 112 124 122 108 126 128 122 121.6667
Rajeswari 25 f 168 66 116 124 118 126 132 120 128 124.6667
Parameswari 28 f 158 62 122 122 126 124 118 116 120 121
43.44 164.4 64.76 119.72 123
13.125 160.88 5.554878 3.0484969 2.180733
BUPIVACAINE FENTANYL GROUP
NAME AGE SEX HEIGHT WEIGHT
PRE OP 
PR
POSTOP 
PR 2 3 4 5 6 AVERAGE
Pannerse 48 m 168 68 76 76 78 88 80 84 86 82
Veerama 48 m 170 72 80 76 82 84 78 86 88 80
Perumal 55 m 168 66 86 84 88 86 90 86 84 86.33
Thiagara 47 m 174 72 88 78 74 76 80 84 86 79.66
Kanmani 30 f 164 68 84 84 80 86 78 82 88 83
Latha 28 f 168 65 80 76 80 84 88 84 86 83
Pandarin 52 m 170 72 82 84 88 90 82 78 86 86
Veerama 48 M 162 50 78 78 80 82 84 86 84 82.333
Ramasam 60 m 168 68 88 84 86 80 84 86 88 84.667
Ragavall 48 f 158 56 86 82 88 86 80 78 86 83.333
periyanay 55 f 160 68 88 86 88 84 88 90 86 87
Mala 21 f 162 64 86 82 78 88 90 86 84 84.667
Radha 60 f 168 67 72 64 68 74 78 72 66 70.333
Saraswat 53 f 166 68 70 68 72 76 70 66 68 70
Vetriselv 35 f 164 64 80 78 84 88 80 82 84 82.667
Mookaye 50 f 156 66 84 88 90 84 88 86 80 86
Saraswat 53 f 154 64 82 74 78 86 80 84 80 80.333
Radha 60 f 158 66 78 78 84 86 74 80 86 81.333
lakshmi 42 f 162 68 70 68 72 76 84 84 86 78.333
Selvi 27 f 168 54 88 84 86 88 82 84 86 85
Ramayee 48 f 156 58 82 72 74 82 84 86 84 80.333
Prabhaka 16 m 166 59 82 82 88 86 84 86 80 84.333
Philip 49 m 174 68 84 86 90 84 82 80 84 84.333
Rajeswar 25 f 168 66 76 72 84 78 82 80 76 78.667
Paramesw 28 f 158 62 76 74 80 84 86 88 84 82.667
43.44 164.4 64.76 81.04 81.853
13.125 160.88 5.554878 5.48087584 4.2536
BUPIVACAINE FENTANYL GROUP
NAME AGE SEX
SEDATION 
SCORE
PAIN 
SCORE 2 3 4 5 6
PAIN 
SCORE
 MOTOR 
BLOCK ADJUVANT
Pannerselvam 48 m 2 1 2 1 2 1 2 2 1 0
Veeramalai 48 m 2 2 2 1 2 2 2 1.833333 1 0
Perumal 55 m 2 2 2 2 1 2 2 1.833333 1 0
Thiagarajan 47 m 2 2 2 1 1 1 1 1.333333 1 0
Kanmani 30 f 2 1 1 2 1 2 1 1.3333 1 0
Latha 28 f 2 2 2 2 1 2 1 1.666667 1 0
Pandarinatha 52 m 2 2 2 2 1 1 1 1.5 1 0
Veeramalai 48 M 2 2 2 2 2 2 2 2 1 0
Ramasamy 60 m 2 1 2 1 1 2 1 1.333333 1 0
Ragavalli 48 f 2 1 2 1 1 2 1 1.333333 1 0
periyanayaki 55 f 2 2 2 2 1 2 2 1.833333 1 0
Mala 21 f 2 2 3 2 2 2 2 2.166667 1 0
Radha 60 f 2 2 2 3 1 2 2 2 1 0
Saraswathy 53 f 2 2 3 2 3 2 2 2.333333 1 0
Vetriselvi 35 f 2 2 3 3 2 2 2 2.333333 1 0
Mookayee 50 f 2 1 2 2 2 2 2 1.833333 1 0
Saraswathy 53 f 2 2 2 3 2 2 2 2.166667 1 0
Radha 60 f 2 1 2 2 2 1 2 1.666667 1 0
lakshmi 42 f 2 2 2 2 1 2 2 1.833333 1 0
Selvi 27 f 2 1 2 2 2 2 2 1.833333 1 0
Ramayee 48 f 2 1 2 2 2 2 2 1.833333 1 0
Prabhakar 16 m 2 1 2 2 2 2 1 1.666667 1 0
Philip 49 m 2 2 2 2 2 1 2 1.833333 1 0
Rajeswari 25 f 2 2 2 2 2 2 2 2 1 0
Parameswari 28 f 2 1 2 2 2 2 1 1.666667 1 0
43.44 2
13.125 0.294709
ROPIVACAINE FENTANYL GROUP
NAME AGE SEX
PREOP 
DIA BP
POST OP 
DIAST BP 2 3 4 5 6
Ravikoundan 57 m 82 84 88 90 86 84 82 85.667
Gurulaksmi 40 f 84 88 90 92 86 84 86 87.667
Anusuya 32 f 70 74 76 84 82 80 84 80
Meenakshi 40 f 86 88 90 92 86 86 84 87.667
Dhanalaksmi 40 f 78 80 84 86 88 78 82 83
Mary 55 f 74 78 82 84 86 76 74 80
Vasantha 50 f 82 84 88 86 84 84 82 84.667
periyakkal 58 f 84 86 88 84 90 84 86 86.333
Bagavathi 48 f 76 78 80 86 84 88 82 83
Latha 25 f 86 88 82 78 76 74 82 80
Jamuna 29 f 74 78 80 74 76 84 82 79
Sumathy 37 F 78 80 84 82 78 86 78 81.333
Rani 56 f 82 88 90 82 84 82 78 84
mari regina 35 f 80 84 82 86 84 82 86 84
Santhakumari 40 f 70 82 84 72 78 82 84 80.333
Lakshikanthan 60 m 68 74 70 76 82 72 84 76.333
Uma 32 f 66 72 68 70 82 84 82 76.333
Mookayee 40 f 72 78 80 86 88 84 82 83
Subaiya 60 m 74 78 76 74 84 88 86 81
tamilarasi 40 f 80 88 92 82 78 76 84 83.333
Marimuthu 30 m 78 80 82 88 86 84 86 84.333
vasantha kumari 45 f 80 84 86 82 80 78 88 83
Sakeela 47 f 82 84 86 88 82 88 80 84.667
shanthi 31 f 70 74 76 78 72 82 84 77.667
Karuppaiya 40 m 72 74 78 80 82 76 84 79
42.68 77.12 82.213
10.491 5.83324 3.2014
AVERAGE
ROPIVACAINE FENTANYL GROUP
NAME AGE SEX HEIGHT WEIGHT
PREOP 
SYS BP
POST OP 
SYSBP 2 3 4 5 6 AVERA
Ravikoundan 57 m 158 65 116 124 126 120 118 124 128 123.33
Gurulaksmi 40 f 152 48 122 126 138 130 140 126 128 131.33
Anusuya 32 f 154 56 120 124 126 130 128 126 124 126.33
Meenakshi 40 f 156 52 118 126 132 134 122 130 132 129.33
Dhanalaksmi 40 f 158 55 126 128 136 124 140 126 132 131
Mary 55 f 156 53 124 126 128 126 130 124 128 127
Vasantha 50 f 158 56 128 130 140 128 138 122 126 130.67
periyakkal 58 f 162 58 122 124 126 120 126 128 124 124.67
Bagavathi 48 f 154 62 118 124 126 122 124 128 126 125
Latha 25 f 158 58 124 138 122 140 128 124 128 130
Jamuna 29 f 160 64 118 122 128 124 126 128 124 125.33
Sumathy 37 F 156 62 124 126 140 124 138 128 126 130.33
Rani 56 f 162 65 110 114 116 118 112 118 114 115.33
mari regina 35 f 158 56 126 142 128 138 126 124 128 131
Santhakumari 40 f 156 58 118 124 128 124 132 126 126 126.67
Lakshikantha 60 m 168 70 124 124 138 120 138 122 124 127.67
Uma 32 f 158 62 118 122 124 128 126 130 124 125.67
Mookayee 40 f 162 64 126 122 138 130 136 128 130 130.67
Subaiya 60 m 174 76 120 122 124 126 124 124 128 124.67
tamilarasi 40 f 164 62 128 126 142 124 140 122 126 130
Marimuthu 30 m 174 72 118 124 126 128 120 132 124 125.67
vasantha kum 45 f 160 58 124 144 122 142 124 126 128 131
Sakeela 47 f 162 64 116 124 126 128 126 128 128 126.67
shanthi 31 f 164 60 128 126 138 130 128 138 126 131
Karuppaiya 40 m 178 76 122 126 128 140 128 142 126 131.67
42.68 160.88 61.28 121.52 127.68
10.491 6.559472 6.99714227 4.51959 3.6874
ROPIVACAINE FENTANYL GROUP
NAME AGE SEX
PREOP 
DIA BP
POST OP 
DIAST BP 2 3 4 5 6
Ravikoundan 57 m 82 84 88 90 86 84 82 85.667
Gurulaksmi 40 f 84 88 90 92 86 84 86 87.667
Anusuya 32 f 70 74 76 84 82 80 84 80
Meenakshi 40 f 86 88 90 92 86 86 84 87.667
Dhanalaksmi 40 f 78 80 84 86 88 78 82 83
Mary 55 f 74 78 82 84 86 76 74 80
Vasantha 50 f 82 84 88 86 84 84 82 84.667
periyakkal 58 f 84 86 88 84 90 84 86 86.333
Bagavathi 48 f 76 78 80 86 84 88 82 83
Latha 25 f 86 88 82 78 76 74 82 80
Jamuna 29 f 74 78 80 74 76 84 82 79
Sumathy 37 F 78 80 84 82 78 86 78 81.333
Rani 56 f 82 88 90 82 84 82 78 84
mari regina 35 f 80 84 82 86 84 82 86 84
Santhakumari 40 f 70 82 84 72 78 82 84 80.333
Lakshikanthan 60 m 68 74 70 76 82 72 84 76.333
Uma 32 f 66 72 68 70 82 84 82 76.333
Mookayee 40 f 72 78 80 86 88 84 82 83
Subaiya 60 m 74 78 76 74 84 88 86 81
tamilarasi 40 f 80 88 92 82 78 76 84 83.333
Marimuthu 30 m 78 80 82 88 86 84 86 84.333
vasantha kumari 45 f 80 84 86 82 80 78 88 83
Sakeela 47 f 82 84 86 88 82 88 80 84.667
shanthi 31 f 70 74 76 78 72 82 84 77.667
Karuppaiya 40 m 72 74 78 80 82 76 84 79
42.68 77.12 82.213
10.491 5.83324 3.2014
AVERAGE
ROPIVACAINE FENTANYL GROUP
NAME AGE SEX
PAIN 
SCORE 2 3 4 5 6 AVERAGEADJUVANT SEDAT
Ravikoundan 57 m 2 3 3 2 3 2 2.5 0 2
Gurulaksmi 40 f 2 1 2 1 2 2 1.6 0 2
Anusuya 32 f 0 1 1 2 1 1 1 0 2
Meenakshi 40 f 1 1 5 2 4 2 2.5 2 2
Dhanalaksmi 40 f 1 2 5 2 6 2 3 2 2
Mary 55 f 1 2 2 1 2 1 1.5 0 2
Vasantha 50 f 1 5 2 4 1 2 2.5 2 2
periyakkal 58 f 1 2 1 2 1 2 1.5 0 2
Bagavathi 48 f 1 2 1 2 2 1 1.5 0 2
Latha 25 f 1 5 2 6 2 2 3 2 2
Jamuna 29 f 0 2 1 1 1 1 1 0 2
Sumathy 37 F 1 4 2 5 2 2 2.666667 2 2
Rani 56 f 1 2 1 2 1 2 1.5 0 2
mari regina 35 f 1 6 2 5 2 2 3 2 2
Santhakumari 40 f 1 2 2 1 2 2 1.666667 0 2
Lakshikanthan 60 m 1 5 2 2 4 2 2.666667 2 2
Uma 32 f 1 2 2 1 1 2 1.5 0 2
Mookayee 40 f 2 6 2 5 2 2 3.166667 2 2
Subaiya 60 m 0 2 2 2 2 2 1.666667 0 2
tamilarasi 40 f 0 5 2 5 2 2 2.66 2 2
Marimuthu 30 m 1 2 2 2 2 1 1.666667 0 2
vasantha kum 45 f 5 2 4 2 2 2 2.833333 2 2
Sakeela 47 f 2 1 2 2 2 2 1.833333 0 2
shanthi 31 f 2 5 3 2 5 2 3.166667 2 2
Karuppaiya 40 m 2 2 5 2 4 1 2.666667 2 2
42.68 2.1704
10.491
